TY - JOUR
T1 - Assessment of Home-based Monitoring in Adults with Chronic Lung Disease An Official American Thoracic Society Research Statement
AU - Khor, Yet H.
AU - Krishnan, Jerry A.
AU - Poberezhets, Vitalii
AU - American Thoracic Society Assembly on Clinical Problems
AU - Wijsenbeek, Marlies S.
AU - Alder, Rachel
AU - Aronson, Kerri I.
AU - Barnes, Teresa
AU - Benzo, Roberto
AU - Birring, Surinder S.
AU - Boyd, Jeanette
AU - Buhr, Russell G.
AU - Chalmers, James D.
AU - Choi, Hayoung
AU - Crossley, Barbara
AU - Fan, Vincent S.
AU - Flewett, Ron
AU - Freedman, Michael
AU - George, Maureen
AU - Gibson, Toni
AU - Holland, Anne E.
AU - Houchen-Wolloff, Linzy
AU - Krishnaswamy, Uma M.
AU - Linnell, John
AU - Martinez, Fernando J.
AU - Moor, Catharina C.
AU - Orr, Hilarry
AU - Pappalardo, Andrea A.
AU - Pinnock, Hilary
AU - Ryerson, Christopher J.
AU - Saraiva, Isabel
AU - Wadell, Karin
AU - Watz, Henrik
N1 - Publisher Copyright:
Copyright © 2025 by the American Thoracic Society.
PY - 2025/2/1
Y1 - 2025/2/1
N2 - Background: There is increasing interest in the use of home-based monitoring in people with chronic lung diseases to improve access to care, support patient self-management, and facilitate the collection of information for clinical care and research. However, integration of home-based monitoring into clinical and research settings requires careful consideration of test performance and other attributes. There is no published guidance from professional respiratory societies to advance the science of home-based monitoring for chronic lung disease. Methods: An international multidisciplinary panel of 32 clinicians, researchers, patients, and caregivers developed a multidimensional framework for the evaluation of home-based monitoring in chronic lung disease developed through consensus using a modified Delphi survey. We also present an example of how the framework could be used to evaluate home-based monitoring using spirometry and pulse oximetry in adults with asthma, bronchiectasis/cystic fibrosis, chronic obstructive pulmonary disease, and interstitial lung disease. Results: The PANACEA framework includes seven domains (test Performance, disease mANAgement, Cost, patient Experience, clinician Experience, researcher Experience, and Access) to assess the degree to which home-based monitoring assessments meet the conditions for clinical and research use in chronic lung disease. Knowledge gaps and recommendations for future research of home spirometry and pulse oximetry in asthma, bronchiectasis/cystic fibrosis, chronic obstructive pulmonary disease, and interstitial lung disease were identified. Conclusions: The development of the PANACEA framework allows standardized evaluation of home-based monitoring in chronic lung diseases to support clinical application and future research.
AB - Background: There is increasing interest in the use of home-based monitoring in people with chronic lung diseases to improve access to care, support patient self-management, and facilitate the collection of information for clinical care and research. However, integration of home-based monitoring into clinical and research settings requires careful consideration of test performance and other attributes. There is no published guidance from professional respiratory societies to advance the science of home-based monitoring for chronic lung disease. Methods: An international multidisciplinary panel of 32 clinicians, researchers, patients, and caregivers developed a multidimensional framework for the evaluation of home-based monitoring in chronic lung disease developed through consensus using a modified Delphi survey. We also present an example of how the framework could be used to evaluate home-based monitoring using spirometry and pulse oximetry in adults with asthma, bronchiectasis/cystic fibrosis, chronic obstructive pulmonary disease, and interstitial lung disease. Results: The PANACEA framework includes seven domains (test Performance, disease mANAgement, Cost, patient Experience, clinician Experience, researcher Experience, and Access) to assess the degree to which home-based monitoring assessments meet the conditions for clinical and research use in chronic lung disease. Knowledge gaps and recommendations for future research of home spirometry and pulse oximetry in asthma, bronchiectasis/cystic fibrosis, chronic obstructive pulmonary disease, and interstitial lung disease were identified. Conclusions: The development of the PANACEA framework allows standardized evaluation of home-based monitoring in chronic lung diseases to support clinical application and future research.
UR - https://www.scopus.com/pages/publications/85217518891
U2 - 10.1164/rccm.202410-2080st
DO - 10.1164/rccm.202410-2080st
M3 - Article
C2 - 39585746
AN - SCOPUS:85217518891
SN - 1073-449X
VL - 211
SP - 174
EP - 193
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
IS - 2
ER -